Eddy Solomon1, Noam Nissan2, Rita Schmidt1, Edna Furman-Haran3, Uriel Ben-Aharon4, and Lucio Frydman1
1Chemical Physics Department, Weizmann Institute of Science, Rehovot, Israel, 2Biological Regulation Department, Weizmann Institute of Science, Rehovot, Israel, 3Unit of Biological Services, Weizmann Institute of Science, Rehovot, Israel, 4Breast Surgery Unit, Meuhedet Clinic, Ashdod, Israel
Synopsis
A new ADC-mapping
methodology based on SPatio-temporal ENcoding (SPEN) was applied to augmented
breasts, organs possessing multiple spectral components. SPEN provides a robust single-shot alternative
to echo-planar-imaging (EPI) in terms of overcoming B0-inhomogeneities,
while being able to resolve—and thereby suppress—the contributions of different
chemical sites. Diffusion SPEN measurements were carried out at 3T on healthy volunteers
with silicone-implant augmentation and compared against SE-EPI counterparts, confirming
SPEN’s ability to yield more reliable ADC maps, free from the dominant silicone
signal contributions, in a single shot. This opens new screening possibilities for cancer detection in
breast augmented patients.Introduction
There
is a growing need for imaging breasts with silicone implants, driven by
augmentation procedures for cosmetic and cancer-related reconstruction purposes
[1]. While the silicone implant’s
integrity accounts for the main radiological concern of these patients, breast
cancer detection and diagnosis remain an important need. A promising non-invasive
method to diagnose breast cancer is diffusion-weighted MRI (DWI) [2], a
diagnosis based on the fact that cancerous tissues exhibit lower apparent
diffusion coefficient (ADCs) than normal fibroglandular tissue or benign
lesions [3]. Diffusion measurements require fast imaging techniques, exhibiting
reduced sensitivity to motional effects. In most cases the method of choice is spin-echo
echo planar imaging (SE-EPI). Still, SE-EPI is prone to display artifacts,
particularly when applied to the examination of challenging organs like
silicone-implanted breasts. Here the presence of water-, silicone-, and
fat-rich regions results in chemical shift artifacts and field heterogeneities,
leading to spurious replicas that may confound the radiological interpretation
[4]. In this work we explore the use of a DWI imaging
methodology based on SPatio-temporal ENcoding (SPEN). This single-shot
technique has proven as a highly robust alternative in terms of overcoming B0-inhomogeneities
and heterogeneous chemical environments [5-6]. An important advantage of SPEN
rests in its ability to resolve—and thereby, if needed, suppress—the
contributions of different chemical sites without any changes in the basic
imaging-oriented pulse sequence [7]. The purpose of this study was to explore the
application of SPEN’s strategies to acquire reliable ADC maps of fibroglandular
tissue in silicone implanted human breasts, whose images have been freed from
the dominant silicone signal contributions.
Methods
This
study was approved by the Institutional Review Board of the Wolfson Medical
Center (Holon, Israel) and included seven healthy volunteers with different
sizes of silicone implants and of fibroglandular tissue. Axial images were
acquired at 3 Tesla (T) on a Siemens TrioTIM scanner using a four-channel
bilateral breast coil. The MRI protocol included a T2-weighted turbo spin-echo
(TSE) followed by DWI acquisitions of twice-refocused SE-EPI and by SPEN DWI with
fat suppression using d=17 ms, ∆=35 ms and n=7
nominal b-values
in the range: 0-750 (s/mm
2). The spatial
resolutions of both SE-EPI and SPEN experiments were 2.0x2.0x2.5 mm
3.
The total scan durations (per slice) were 180 ms and 277 ms for DWI SPEN and
SE-EPI, respectively.
Results
While
SPEN’s image retrieval process does not require Fourier processing, it follows
that FT along the SPEN/time acquisition axis, will yield the sample’s chemical
shift spectrum [7]. In this way SPEN provides the basis for single-scan spectroscopic
imaging; individual contributions arising from each chemical resolved site can then
be manually isolated (or removed). Figure 1a shows a TSE multi-shot scan of a healthy volunteer including the silicone implant,
the fibroglandular tissue, and the fatty tissue. Following SPEN’s spectral filtration procedure, we were able to selectively
separate the fibroglandular tissue (Fig. 1c) and the silicone implant (Fig. 1d)
– both from the same single-scan information.
Additionally, utilized in Figure 1 was SPEN’s capability to “zoom” on a
single breast, while avoiding folding. Figure 2
shows a representative scan of a healthy volunteer, presenting a TSE image (Fig. 2a), as well as anatomical b-zero images (Fig. 2b) and ADC maps
(Fig. 2c) delivered by DWI SE-EPI and by SPEN, respectively. To avoid
folding artifacts the FOV used in the SE-EPI was chosen to cover the whole
body, whereas in the folding-free SPEN scans the FOV could be reduced to half
this size. b-zero images afforded by
SE-EPI show a noticeable chemical shift displacement artifact of the silicone
implant, which together with a sizable ghost of both the water and silicone
signals (yellow arrows in Fig. 2b) appear below the fibroglandular tissue. Under
similar conditions SPEN succeeds to deliver images that are significantly less
influenced by ghosts, showing the fibroglandular tissue in its right location
and a considerably weaker silicone contribution. Analyses of diffusion
values measured in breast ROIs (red circled ROIs
indicated in Fig. 2c), revealed no significant differences between the
ADCs derived from SE-EPI and from SPEN (SE-EPI ADC
=1.57±0.18 x10
-3 mm
2/s,
SPEN ADC =1.56±0.12 x10
-3 mm
2/s,
tailed p = 0.16).
Conclusions
This study explored the use of SPEN–based strategies incorporating ADC measurements
in the presence of silicone implant.
This includes single-scan images that are less affected by field
inhomogeneities than SE-EPI’s counterparts, as well as SPEN’s built-in capacity
to separate multiple spectral contributions without demanding additions or
modifications to the original single-scan 2D imaging sequence, thereby opening new screening possibilities for
the identification of malignancies in breast augmented patients.
Financial support
EU, Kimmel
Institute and Perlman Family
Foundation.
Acknowledgements
No acknowledgement found.References
[1] Stoblen F et al. Insights Imaging 2010;1:93–97. [2]
Sharma U et al. NMR Biomed 2009;22: 104–113. [3] Guo, Y et al. J Magn Reson
Imaging. 2002;16:172-8. [4] Farzaneh F et al. Magn Reson Med
1990;14:123–139. [5] Schmidt R et al. Magn Reson Med. 2013;70:382-9. [6] Solomon E et al. Magn Reson
Med 2015; 73:2163–2173. [7] Tal A et al.
J Magn Reson 2007;189:46–58.